Cargando…
Combinatorial targeting of FGF and ErbB receptors blocks growth and metastatic spread of breast cancer models
INTRODUCTION: Targeting receptor tyrosine kinases (RTKs) with kinase inhibitors is a clinically validated anti-cancer approach. However, blocking one signaling pathway is often not sufficient to cause tumor regression and the effectiveness of individual inhibitors is often short-lived. As alteration...
| Autores principales: | , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2013
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3672810/ https://www.ncbi.nlm.nih.gov/pubmed/23343422 http://dx.doi.org/10.1186/bcr3379 |